International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01
Drug-induced liver hypersensitivity disease is a relatively rare condition, but can have serious consequences for the individual patient, public health, regulatory agencies and the pharmaceutical industry. It is characterised by elevation in serum alanine-aminotransferase (ALT), conjugated bilirubin, or combined bilirubin, ALT and alkaline phosphatase (AP) levels > 2 times the upper limit of normal (ULN) and the most frequent related drugs are halothane, tienilic acid, dihydralazine, diclofenac, and carbamazepine.
postcoordination
Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Associated with - multiple selections are allowed
synonyms
Drug-induced liver hypersensitivity disease
medicament-induced liver hypersensitivity disease
Immune-mediated DILI - [drug-induced liver injury]
Quick, Current, Complete - www.findacode.com